The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer

The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer

Abstract Background Treatment for local and locoregional recurrence or second head-and-neck (H&N) cancers after previous radiotherapy is challenging, and re-irradiation carries a significantly increased risk for radiotherapy-related normal tissue toxicities and treatment failure due to a radiore...

Full description

Bibliographic Details
Main Authors: Alexander Rühle, Tanja Sprave, Tobias Kalckreuth, Raluca Stoian, Erik Haehl, Constantinos Zamboglou, Roland Laszig, Andreas Knopf, Anca-Ligia Grosu, Nils H. Nicolay
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Radiation Oncology
Subjects:
Head-and-neck cancer
Head-and-neck squamous cell carcinoma (HNSCC)
Recurrent head-and-neck cancer
Re-irradiation
Radiotherapy
Chemotherapy
Online Access:http://link.springer.com/article/10.1186/s13014-020-01531-5

Internet

http://link.springer.com/article/10.1186/s13014-020-01531-5

Similar Items